NICE is also looking at the role of Hympavzi in treating severe haemophilia A, where there are other subcutaneous options ...

According to the CDC, cases of myocarditis and pericarditis are rare with the vaccines and in most cases resolve within a few ...

For J&J, there was a positive outcome as the Oncologic Drugs Advisory Committee (ODAC) voted six to two in favour of approval ...

Arguably, the step historically limiting growth of the radiotherapeutics sector is radioisotope generation. Isotopes are ...

Sexual health services in the UK will start rolling out a 'world-first' vaccine programme designed to protect people from ...

The policy has been outlined in an editorial in the New England Journal of Medicine (NEJM) by FDA Commissioner Marty Makary ...

President Donald Trump's plan to introduce a most favoured nation (MFN) system of drug pricing controls is not quite what he ...

German biopharma company BioNTech has said it will commit up to £1 billion ($1.34 billion) in investment in the UK over the ...

The drug – which is an intranasal formulation of 5-MeO-DMT benzoate, a psychoactive compound found in a wide variety of plant ...

Nanoelectronics specialist Imec will demonstrate a miniaturised, ingestible sensor device today that can monitor ...

The revitalisation of GSK's blood cancer therapy Blenrep has continued with a second regulatory approval, in Japan, as a ...

France's Sanofi is the latest European pharma group to promise a big capital investment programme on manufacturing and R&D in ...